ADVERTISEMENT

Volume 103

Pages 1-654 (February 2021)

Actions for selected articles

/

Contents

Receive an update when the latest issues in this journal are published
Sign in to set up alerts
    1. Editorial Board

      Page i
      Download PDF
  1. Coronavirus (COVID-19) Collection

    1. The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment?

      Pages 1-2
      Download PDF
    2. Clinical and epidemiological features discriminating confirmed COVID-19 patients from SARS-CoV-2 negative patients at screening centres in Madagascar

      Pages 6-8
      Download PDF
    3. Increasing SARS-CoV-2 RT-qPCR testing capacity by sample pooling

      Pages 19-22
      Download PDF
    4. SARS-CoV-2 sensitivity limbo – How low can we go?

      Pages 23-24
      Download PDF
    5. CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14

      Pages 25-32
      Download PDF
    6. Low-dose and oral exposure to SARS-CoV-2 may help us understand and prevent severe COVID-19

      Pages 37-41
      Download PDF
    7. Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial

      Pages 62-71
      Download PDF
    8. Pandemic risk of COVID-19 outbreak in the United States: An analysis of network connectedness with air travel data

      Pages 97-101
      Download PDF
    9. Spread of COVID-19 and policy responses in Vietnam: An overview

      Pages 157-161
      Download PDF
    10. Reply to a comment on meta-analysis on facemask use in community settings

      Pages 162-163
      Download PDF
    11. A novel use of telemedicine during the COVID-19 pandemic

      Pages 182-187
      Download PDF
    12. Pneumonia in medical professionals during COVID-19 outbreak in cardiovascular hospital

      Pages 188-193
      Download PDF
    13. A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

      Pages 214-216
      Download PDF
    14. Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report

      Pages 234-241
      Download PDF
    15. Asymptomatic patients as a source of transmission of COVID-19 in homeless shelters

      Pages 243-245
      Download PDF
    16. Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis

      Pages 246-256
      Download PDF
    17. Meta-analysis on facemask use in community settings to prevent respiratory infection transmission shows no effect

      Pages 257-259
      Download PDF
    18. Algorithms for testing COVID-19 focused on use of RT-PCR and high-affinity serological testing: A consensus statement from a panel of Latin American experts

      Pages 260-267
      Download PDF
    19. COVID-19: A PCR-defined pandemic

      Pages 278-279
      Download PDF
    20. Evolution and genetic diversity of SARS-CoV-2 in Africa using whole genome sequences

      Pages 282-287
      Download PDF
    21. Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study

      Pages 288-296
      Download PDF
    22. Novaferon, treatment in COVID-19 patients

      Page 297
      Download PDF
    23. Unique pattern of COVID-19 infection in the State of Hawai‘i

      Pages 298-299
      Download PDF
    24. A high-throughput drug screening strategy against coronaviruses

      Pages 300-304
      Download PDF
    25. Genomic sequencing effort for SARS-CoV-2 by country during the pandemic

      Pages 305-307
      Download PDF
    26. Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany

      Pages 316-322
      Download PDF
    27. Demographic shift in COVID-19 patients in Singapore from an aged, at-risk population to young migrant workers with reduced risk of severe disease

      Pages 329-335
      Download PDF
    28. Reply to “Novaferon, treatment in COVID-19 patients”

      Pages 336-337
      Download PDF
    29. Monitoring for outbreak-associated excess mortality in an African city: Detection limits in Antananarivo, Madagascar

      Pages 338-342
      Download PDF
    30. An influenza A (H3N2) virus outbreak in the Kingdom of Cambodia during the COVID-19 pandemic of 2020

      Pages 352-357
      Download PDF
    31. Higher pharyngeal epithelial gene expression of angiotensin-converting Enzyme-2 in patients with upper respiratory infection

      Pages 378-380
      Download PDF
    32. Comparison of six commercially available SARS-CoV-2 antibody assays—Choice of assay depends on intended use

      Pages 381-388
      Download PDF
    33. SARS-CoV-2 in migrant worker dormitories: Geospatial epidemiology supporting outbreak management

      Pages 389-394
      Download PDF
    34. Retrospective study identifies infection related risk factors in close contacts during COVID-19 epidemic

      Pages 395-401
      Download PDF
    35. More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine

      Pages 402-403
      Download PDF
    36. Role of the complement system in antibody-dependent enhancement of flavivirus infections

      Pages 404-411
      Download PDF
    37. A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient

      Pages 412-414
      Download PDF
    38. Hypoxic preconditioning — A nonpharmacological approach in COVID-19 prevention

      Pages 415-419
      Download PDF
    39. Nerve conduction study and electromyography findings in patients recovering from Covid-19 – Case report

      Pages 420-422
      Download PDF
    40. Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study

      Pages 431-438
      Download PDF
    41. COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study

      Pages 439-446
      Download PDF
    42. Exploring the link between risk perception in internet media and the prevalence of COVID-19 in Europe

      Pages 450-451
      Download PDF
    43. Oxygen metabolism markers as predictors of mortality in severe COVID-19

      Pages 452-456
      Download PDF
    44. Response to correspondence concerning: “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”

      Pages 478-479
      Download PDF
    45. Serological evidence indicates widespread distribution of rickettsioses in Myanmar

      Pages 494-501
      Download PDF
    46. Thalidomide combined with short-term low-dose glucocorticoid therapy for the treatment of severe COVID-19: A case-series study

      Pages 507-513
      Download PDF
    47. Comparison of hospital treatment strategy or of treatment actually received in COVID-19?: Commenting on: Lammers AJJ, Brohet RM, Theunissen REP, Koster C, Rood R, Verhagen DWM, et al. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients. Int J Infect Dis. 2020 September

      Page 516
      Download PDF
    48. Simultaneous detection and differentiation of SARS-CoV-2, influenza A virus and influenza B virus by one-step quadruplex real-time RT-PCR in patients with clinical manifestations

      Pages 517-524
      Download PDF
    49. Institut Pasteur International Network’s efforts to guide control measures against the coronavirus disease 2019 (COVID-19) epidemic among healthcare workers in Africa

      Pages 525-526
      Download PDF
    50. Tocilizumab in the treatment of critical COVID-19 pneumonia: A retrospective cohort study of mechanically ventilated patients

      Pages 536-539
      Download PDF
    51. Dynamic anti-spike protein antibody profiles in COVID-19 patients

      Pages 540-548
      Download PDF
    52. Severe type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences

      Pages 549-551
      Download PDF
    53. Response to “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”

      Pages 560-561
      Download PDF
    54. Transmission dynamics of the COVID-19 epidemic in India and modeling optimal lockdown exit strategies

      Pages 579-589
      Download PDF
    55. Clinical evaluation of commercial automated SARS-CoV-2 immunoassays

      Pages 590-596
      Download PDF
    56. An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy

      Pages 599-606
      Download PDF
    57. Down Syndrome patients with COVID-19 pneumonia: A high-risk category for unfavourable outcome

      Pages 607-610
      Download PDF
    58. Higher binding affinity of furin for SARS-CoV-2 spike (S) protein D614G mutant could be associated with higher SARS-CoV-2 infectivity

      Pages 611-616
      Download PDF
    59. The time-varying transmission dynamics of COVID-19 and synchronous public health interventions in China

      Pages 617-623
      Download PDF
    60. Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson’s disease: Balancing immunosuppression

      Pages 624-627
      Download PDF
    61. B cell depletion and signs of sepsis-acquired immunodeficiency in bone marrow and spleen of COVID-19 deceased

      Pages 628-635
      Download PDF
    62. Clinical performance evaluation of a SARS-CoV-2 Rapid Antibody Test for determining past exposure to SARS-CoV-2

      Pages 636-641
      Download PDF
    63. Clinical characteristics of 30 COVID-19 patients with epilepsy: A retrospective study in Wuhan

      Pages 647-653
      Download PDF
  2. Perspective

    1. A critical assessment of proposed outbreaks of plague and other epidemic diseases in Ancient Egypt

      Pages 217-219
      Download PDF
  3. Reviews

    1. Methicillin-resistant Staphylococcus aureus in Nepal: A systematic review and meta-analysis

      Pages 48-55
      Download PDF
    2. Healthcare-associated outbreaks of bacterial infections in Africa, 2009–2018: A review

      Pages 469-477
      Download PDF
  4. Original Reports

    1. Plasmid-borne colistin resistance gene mcr-1 in a multidrug resistant Salmonella enterica serovar Typhimurium isolate from an infant with acute diarrhea in China

      Pages 13-18
      Download PDF
    2. Evaluation of a novel urinary antigen test kit for diagnosing Legionella pneumonia

      Pages 42-47
      Download PDF
    3. Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosis

      Pages 56-61
      Download PDF
    4. Genetic diversity of the Mycobacterium tuberculosis complex strains from newly diagnosed tuberculosis patients in Northwest Ethiopia reveals a predominance of East-African-Indian and Euro-American lineages

      Pages 72-80
      Download PDF
    5. Metagenomic next-generation sequencing technology for detection of pathogens in blood of critically ill patients

      Pages 81-87
      Download PDF
    6. Clinical efficacy of metagenomic next-generation sequencing for rapid detection of Mycobacterium tuberculosis in smear-negative extrapulmonary specimens in a high tuberculosis burden area

      Pages 91-96
      Download PDF
    7. Cost of multidrug resistant tuberculosis in Germany—An update

      Pages 102-109
      Download PDF
    8. Novel stepwise approach to assess representativeness of a large multicenter observational cohort of tuberculosis patients: The example of RePORT Brazil

      Pages 110-118
      Download PDF
    9. High prevalence of antibiotic-resistant Escherichia coli in Congolese students

      Pages 119-123
      Download PDF
    10. Acute kidney injury and mortality in pediatric Lassa fever versus question of access to dialysis

      Pages 124-131
      Download PDF
    11. Distribution and resistance of pathogens in infected patients within 1 year after heart transplantation

      Pages 132-137
      Download PDF
    12. Clinical and epidemiological study of cutaneous leishmaniasis in two tertiary care hospitals of Jammu and Kashmir: An emerging disease in North India

      Pages 138-145
      Download PDF
    13. Hepatitis A outbreak among MSM in Berlin due to low vaccination coverage: Epidemiology, management, and successful interventions

      Pages 146-153
      Download PDF
    14. Effect of nurse-led, goal-directed lung physiotherapy on prognosis of patients with sepsis caused by Acinetobacter baumannii pulmonary infection

      Pages 167-172
      Download PDF
    15. The economic and health burdens of diseases caused by group A Streptococcus in New Zealand

      Pages 176-181
      Download PDF
    16. Significant symptoms and nonsymptom-related factors for malaria diagnosis in endemic regions of Indonesia

      Pages 194-200
      Download PDF
    17. Laboratory-confirmed bloodstream infections in two large neonatal units in sub-Saharan Africa

      Pages 201-207
      Download PDF
    18. The impact of a stewardship program on antibiotic administration in community-acquired pneumonia: Results from an observational before-after study

      Pages 208-213
      Download PDF
    19. Successful expansion of Mycobacterium tuberculosis Latin American and Mediterranean sublineage (L4.3/LAM) in Tunisia mainly driven by a single, long-established clonal complex

      Pages 220-225
      Download PDF
    20. Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection — An observational cohort study

      Pages 226-233
      Download PDF
    21. Source attributed case-control study of campylobacteriosis in New Zealand

      Pages 268-277
      Download PDF
    22. Reduction of 30-day death rates from Staphylococcus aureus bacteremia by mandatory infectious diseases consultation: Comparative study interventions with and without an infectious disease specialist

      Pages 308-315
      Download PDF
    23. Crimean-Congo Hemorrhagic Fever (CCHF) in Afghanistan: A retrospective single center study

      Pages 323-328
      Download PDF
    24. Current spectrum of causative pathogens in sepsis: A prospective nationwide cohort study in Japan

      Pages 343-351
      Download PDF
    25. Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial

      Pages 358-363
      Download PDF
    26. Bone penetration of linezolid in osteoarticular tuberculosis patients of China

      Pages 364-369
      Download PDF
    27. CD4+ and CD8+ cell populations in HIV-positive women with cervical squamous intra-epithelial lesions and squamous cell carcinoma

      Pages 370-377
      Download PDF
    28. Helicobacter pylori, clinical, laboratory, and noninvasive biomarkers suggestive of gastric damage in healthy school-aged children: A case-control study

      Pages 423-430
      Download PDF
    29. Cerebral alterations in West African HIV and non-HIV adults aged ≥50: An MRI study

      Pages 457-463
      Download PDF
    30. Stability of antimicrobial agents in an elastomeric infusion pump used for outpatient parenteral antimicrobial therapy

      Pages 464-468
      Download PDF
    31. Prevalence, genotypes and phylogenetic analysis of human papillomaviruses (HPV) in northeast Iran

      Pages 480-488
      Download PDF
    32. Morbidity and mortality of respiratory syncytial virus infection in hospitalized adults: Comparison with seasonal influenza

      Pages 489-493
      Download PDF
    33. Seroprevalence of West Nile Virus among Healthy Blood Donors from Different National Populations Residing in Qatar

      Pages 502-506
      Download PDF

ISSN: 1201-9712